Clinical Trial
. 2008 Mar 5;299(9):1019-26. doi: 10.1001/jama.299.9.1019. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial Kathryn A Winter, Ross A Abrams, Howard Safran, John P Hoffman, Andre Konski, Al B Benson, John S Macdonald, Mahesh R Kudrimoti, Mitchel L Fromm, Michael G Haddock, Paul Schaefer, Christopher G Willett, Tyvin A RichAffiliations
AffiliationItem in Clipboard
Clinical Trial
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trialWilliam F Regine et al. JAMA. 2008.
. 2008 Mar 5;299(9):1019-26. doi: 10.1001/jama.299.9.1019. Authors William F Regine 1 , Kathryn A Winter, Ross A Abrams, Howard Safran, John P Hoffman, Andre Konski, Al B Benson, John S Macdonald, Mahesh R Kudrimoti, Mitchel L Fromm, Michael G Haddock, Paul Schaefer, Christopher G Willett, Tyvin A Rich AffiliationItem in Clipboard
Erratum inContext: Among patients with locally advanced metastatic pancreatic adenocarcinoma, gemcitabine has been shown to improve outcomes compared with fluorouracil.
Objective: To determine if the addition of gemcitabine to adjuvant fluorouracil chemoradiation (chemotherapy plus radiation) improves survival for patients with resected pancreatic adenocarcinoma.
Design, setting, and participants: Randomized controlled phase 3 trial of patients with complete gross total resection of pancreatic adenocarcinoma and no prior radiation or chemotherapy enrolled between July 1998 and July 2002 with follow-up through August 18, 2006, at 164 US and Canadian institutions.
Intervention: Chemotherapy with either fluorouracil (continuous infusion of 250 mg/m2 per day; n = 230) or gemcitabine (30-minute infusion of 1000 mg/m2 once per week; n = 221) for 3 weeks prior to chemoradiation therapy and for 12 weeks after chemoradiation therapy. Chemoradiation with a continuous infusion of fluorouracil (250 mg/m2 per day) was the same for all patients (50.4 Gy).
Main outcome measures: Survival for all patients and survival for patients with pancreatic head tumors were the primary end points. Secondary end points included toxicity.
Results: A total of 451 patients were randomized, eligible, and analyzable. Patients with pancreatic head tumors (n = 388) had a median survival of 20.5 months and a 3-year survival of 31% in the gemcitabine group vs a median survival of 16.9 months and a 3-year survival of 22% in the fluorouracil group (hazard ratio, 0.82 [95% confidence interval, 0.65-1.03]; P = .09). The treatment effect was strengthened on multivariate analysis (hazard ratio, 0.80 [95% confidence interval, 0.63-1.00]; P = .05). Grade 4 hematologic toxicity was 1% in the fluorouracil group and 14% in the gemcitabine group (P < .001) without a difference in febrile neutropenia or infection. There were no differences in the ability to complete chemotherapy or radiation therapy (>85%).
Conclusions: The addition of gemcitabine to adjuvant fluorouracil-based chemoradiation was associated with a survival benefit for patients with resected pancreatic cancer, although this improvement was not statistically significant.
Trial registration: clinicaltrials.gov Identifier: NCT00003216.
Similar articlesNeoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275. JAMA. 2010. PMID: 20823433 Clinical Trial.
Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA. Crane CH, et al. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302. doi: 10.1016/s0360-3016(01)02740-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955742
Kachnic LA, Shaw JE, Manning MA, Lauve AD, Neifeld JP. Kachnic LA, et al. Int J Cancer. 2001 Apr 20;96(2):132-9. doi: 10.1002/ijc.1008. Int J Cancer. 2001. PMID: 11291097 Clinical Trial.
Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C. Flandin I, et al. Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7. Cancer Radiother. 2004. PMID: 15679252 Review. French.
Claude L, Mornex F. Claude L, et al. Cancer Radiother. 2003 Aug;7(4):254-65. doi: 10.1016/s1278-3218(03)00027-1. Cancer Radiother. 2003. PMID: 12914858 Review. French.
Gunturu KS, Rossi GR, Saif MW. Gunturu KS, et al. Ther Adv Med Oncol. 2013 Jan;5(1):81-9. doi: 10.1177/1758834012462463. Ther Adv Med Oncol. 2013. PMID: 23323149 Free PMC article.
Taboada AGM, Lominchar PL, Roman LM, García-Alfonso P, Martin AJM, Rodriguez JAB, Pascual JMA. Taboada AGM, et al. Ann Hepatobiliary Pancreat Surg. 2021 May 31;25(2):179-191. doi: 10.14701/ahbps.2021.25.2.179. Ann Hepatobiliary Pancreat Surg. 2021. PMID: 34053920 Free PMC article. Review.
Raissouni S, Rais G, Mrabti H, Raissouni F, Mouzount H, Aitelhaj M, El Khoyaali S, Mohtaram A, Errihani H. Raissouni S, et al. J Gastrointest Cancer. 2012 Dec;43(4):607-11. doi: 10.1007/s12029-012-9407-0. J Gastrointest Cancer. 2012. PMID: 22760710
Herman JM, Fan KY, Wild AT, Hacker-Prietz A, Wood LD, Blackford AL, Ellsworth S, Zheng L, Le DT, De Jesus-Acosta A, Hidalgo M, Donehower RC, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Wolfgang CL. Herman JM, et al. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):678-85. doi: 10.1016/j.ijrobp.2013.03.032. Int J Radiat Oncol Biol Phys. 2013. PMID: 23773391 Free PMC article. Clinical Trial.
Postlewait LM, Kooby DA. Postlewait LM, et al. J Gastrointest Oncol. 2015 Aug;6(4):406-17. doi: 10.3978/j.issn.2078-6891.2015.034. J Gastrointest Oncol. 2015. PMID: 26261727 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3